Literature DB >> 30706390

Practical Considerations for the Use of DREADD and Other Chemogenetic Receptors to Regulate Neuronal Activity in the Mammalian Brain.

Patrick Aldrin-Kirk1, Tomas Björklund2.   

Abstract

Chemogenetics is the process of genetically expressing a macromolecule receptor capable of modulating the activity of the cell in response to selective chemical ligand. This chapter will cover the chemogenetic technologies that are available to date, focusing on the commonly available engineered or otherwise modified ligand-gated ion channels and G-protein-coupled receptors in the context of neuromodulation. First, we will give a brief overview of each chemogenetic approach as well as in vitro/in vivo applications, then we will list their strengths and weaknesses. Finally, we will provide tips for ligand application in each case.Each technology has specific limitations that make them more or less suitable for different applications in neuroscience although we will focus mainly on the most commonly used and versatile family named designer receptors exclusively activated by designer drugs or DREADDs. We here describe the most common cases where these can be implemented and provide tips on how and where these technologies can be applied in the field of neuroscience.

Entities:  

Keywords:  Allatostatin; Chemogenetics; DREADD; Engineered receptors; G-Protein-coupled receptor; Gene therapy; GluCl; Ligand; Ligand-gated ion channel; Neuronal modulation; PSAM/PSEM; TRPV1

Mesh:

Substances:

Year:  2019        PMID: 30706390     DOI: 10.1007/978-1-4939-9065-8_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands.

Authors:  Raphaël Goutaudier; Véronique Coizet; Carole Carcenac; Sebastien Carnicella
Journal:  eNeuro       Date:  2019-10-14

2.  Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats.

Authors:  Raphaël Goutaudier; Véronique Coizet; Carole Carcenac; Sebastien Carnicella
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

Review 3.  Parvalbumin Role in Epilepsy and Psychiatric Comorbidities: From Mechanism to Intervention.

Authors:  Lívea Dornela Godoy; Tamiris Prizon; Matheus Teixeira Rossignoli; João Pereira Leite; José Luiz Liberato
Journal:  Front Integr Neurosci       Date:  2022-02-17

4.  The Reuniens Nucleus of the Thalamus Has an Essential Role in Coordinating Slow-Wave Activity between Neocortex and Hippocampus.

Authors:  Brandon E Hauer; Silvia Pagliardini; Clayton T Dickson
Journal:  eNeuro       Date:  2019-10-17

Review 5.  Targeted activation of spinal respiratory neural circuits.

Authors:  Michael D Sunshine; Tommy W Sutor; Emily J Fox; David D Fuller
Journal:  Exp Neurol       Date:  2020-02-19       Impact factor: 5.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.